Core Insights - RingCentral (RNG) reported quarterly earnings of $1.18 per share, exceeding the Zacks Consensus Estimate of $1.14 per share, and up from $0.98 per share a year ago [1] - The company achieved a revenue of $644.03 million for the quarter, surpassing the Zacks Consensus Estimate by 0.27%, compared to $614.51 million in the same quarter last year [3] Earnings Performance - The earnings surprise for the quarter was +3.69%, and the company has surpassed consensus EPS estimates in all four of the last quarters [2] - RingCentral's shares have increased by approximately 2.4% since the beginning of the year, outperforming the S&P 500's gain of 0.5% [4] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $1.07 on revenues of $639.58 million, and for the current fiscal year, it is $4.69 on revenues of $2.62 billion [8] - The estimate revisions trend for RingCentral was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [7] Industry Context - The Internet - Software and Services industry, to which RingCentral belongs, is currently ranked in the bottom 43% of over 250 Zacks industries, suggesting potential challenges ahead [9] - Comparatively, Globant (GLOB), another company in the same industry, is expected to report a year-over-year earnings decline of 12% in its upcoming results [10]

分组1 - Live Nation reported a quarterly loss of $1.06 per share, slightly better than the Zacks Consensus Estimate of a loss of $1.08, compared to earnings of $0.56 per share a year ago, indicating an earnings surprise of +2.20% [1] - The company posted revenues of $6.31 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 3.97%, and showing an increase from $5.68 billion in the same quarter last year [2] - Live Nation shares have increased by approximately 9.3% since the beginning of the year, outperforming the S&P 500's gain of 0.5% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$0.23 on revenues of $3.62 billion, and for the current fiscal year, it is $2.05 on revenues of $27.21 billion [7] - The Zacks Industry Rank for Film and Television Production and Distribution is currently in the bottom 20% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [8]

分组1 - Sprouts Farmers reported quarterly earnings of $0.92 per share, exceeding the Zacks Consensus Estimate of $0.89 per share, and up from $0.79 per share a year ago, representing an earnings surprise of +3.66% [1] - The company posted revenues of $2.15 billion for the quarter ended December 2025, which was 0.51% below the Zacks Consensus Estimate, but an increase from $2 billion in the same quarter last year [2] - Sprouts Farmers has surpassed consensus EPS estimates in all four of the last quarters and has topped consensus revenue estimates two times during the same period [2] 分组2 - The stock has underperformed, losing about 15.1% since the beginning of the year, while the S&P 500 has gained 0.5% [3] - The current consensus EPS estimate for the upcoming quarter is $1.78 on revenues of $2.42 billion, and for the current fiscal year, it is $5.57 on revenues of $9.68 billion [7] - The Zacks Industry Rank for Food - Natural Foods Products is in the bottom 22% of over 250 Zacks industries, indicating potential challenges for the stock's performance [8]

分组1 - Ardelyx reported break-even quarterly earnings per share, matching the Zacks Consensus Estimate of $0.02, with a year-ago comparison of $0.02 per share [1] - The company achieved revenues of $125.22 million for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 6.51% and showing an increase from $116.13 million year-over-year [2] - Ardelyx shares have increased approximately 15.3% since the beginning of the year, outperforming the S&P 500's gain of 0.5% [3] 分组2 - The earnings outlook for Ardelyx is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the upcoming quarter is -$0.01 on revenues of $111.28 million, and for the current fiscal year, it is $0.23 on revenues of $534.79 million [7] - The Medical - Drugs industry, to which Ardelyx belongs, is currently ranked in the bottom 47% of over 250 Zacks industries, indicating potential challenges for stock performance [8]

Group 1 - Zebra Technologies (ZBRA) shares have increased by 3.9% over the past four weeks, closing at $252.52, with a mean price target of $348.5 indicating a potential upside of 38% [1] - The average of 14 short-term price targets ranges from a low of $294.00 to a high of $421.00, with a standard deviation of $33.34, suggesting a potential increase of 16.4% to 66.7% from the current price [2] - Analysts show strong agreement on ZBRA's ability to report better earnings than previously predicted, which supports the view of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for the current year has risen by 4.4% over the past month, with three estimates increasing and no negative revisions [12] - ZBRA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] - While consensus price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movement [14]

Core Viewpoint - Petrobras (PBR) is showing potential as a bullish investment opportunity after reaching a key support level and surpassing the 20-day moving average, indicating a short-term positive trend [1][4]. Technical Analysis - PBR has recently overtaken the 20-day simple moving average, which is a commonly used tool among traders to assess short-term price trends and smooth out fluctuations [1][2]. - The stock's price moving above the 20-day moving average suggests a positive trend, while a drop below it would indicate a downward trend [2]. Performance Metrics - Over the past four weeks, PBR has experienced a gain of 13.2%, reflecting strong performance [4]. - The company currently holds a Zacks Rank of 3 (Hold), suggesting that there is potential for further upward movement in the stock [4]. Earnings Estimates - There have been two upward revisions in earnings estimates for the current fiscal year, with no downward revisions, indicating growing confidence among investors [4]. - The consensus estimate for PBR has also increased, reinforcing the bullish outlook for the stock [4][5]. Investment Outlook - The combination of positive earnings estimate revisions and the stock hitting a key technical level suggests that investors should monitor PBR for potential gains in the near future [5].

分组1 - Travelzoo reported break-even quarterly earnings per share, missing the Zacks Consensus Estimate of $0.11, and compared to earnings of $0.26 per share a year ago, representing an earnings surprise of -100.00% [1] - The company posted revenues of $22.47 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 0.3%, and this is an increase from year-ago revenues of $20.68 million [2] - Travelzoo shares have lost about 20.4% since the beginning of the year, while the S&P 500 has gained 0.5% [3] 分组2 - The current consensus EPS estimate for the coming quarter is $0.29 on $25.8 million in revenues, and for the current fiscal year, it is $1.16 on $107.4 million in revenues [7] - The Zacks Industry Rank indicates that the Internet - Commerce sector is currently in the bottom 23% of over 250 Zacks industries, suggesting that the outlook for the industry can significantly impact stock performance [8]

Wall Street analysts expect MercadoLibre (MELI) to post quarterly earnings of $11.77 per share in its upcoming report, which indicates a year-over-year decline of 6.7%. Revenues are expected to be $8.52 billion, up 40.5% from the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 2.5% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Prior to a company's earnings r ...

Core Viewpoint - Realty Income Corp. is expected to report quarterly earnings of $1.08 per share, reflecting a 2.9% increase year-over-year, with revenues projected at $1.46 billion, indicating a 9.1% year-over-year growth [1]. Earnings Estimates - Over the last 30 days, the consensus EPS estimate for the quarter has been revised upward by 0.3%, indicating analysts' reassessment of their initial forecasts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and are linked to short-term stock price performance [3]. Revenue Projections - The consensus estimate for 'Revenue- Rental (including reimbursable)' is $1.38 billion, representing a 7.9% increase from the previous year [5]. - 'Revenue- Other' is expected to reach $79.45 million, showing a significant increase of 31.1% year-over-year [5]. - 'Revenue- Rental (excluding reimbursable)' is projected at $1.30 billion, indicating an 8% increase from the prior-year quarter [6]. - 'Revenue- Rental (reimbursable)' is estimated at $84.47 million, reflecting an 11.9% year-over-year change [6]. Depreciation and Amortization - Analysts predict 'Depreciation and amortization' will reach $646.96 million [6]. Stock Performance - Realty Income Corp. shares have returned +5.3% over the past month, contrasting with the Zacks S&P 500 composite's -0.8% change, and the company holds a Zacks Rank 3 (Hold) [6].

Analysts on Wall Street project that Elanco Animal Health Incorporated (ELAN) will announce quarterly earnings of $0.11 per share in its forthcoming report, representing a decline of 21.4% year over year. Revenues are projected to reach $1.09 billion, increasing 7.1% from the same quarter last year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Prior ...